As the survival of premature infants increases, the number of babies with bronchopulmonary dysplasia (BPD) rises. The Bronchopulmonary Dysplasia Treatment Center at Children's Hospital has led BPD care and research for more than 30 years.
Our family-centered approach empowers you and your family as knowledgeable caregivers and active members of the medical team. As a team member, you help to identify problems, create a care plan based on your child's needs and family's resources and track progress.
Because improvement for any infant with BPD is gradual and the length of treatment in our center can change, we value supporting your family throughout the healing process.
As part of Vanderbilt University Medical Center, we offer access to the newest therapies developed from medical discoveries made right here. Vanderbilt is one of five neonatal clinical research centers in the U.S. awarded Prematurity and Respiratory Outcomes Program (PROP) funding by the National Institutes of Health (NIH) and the National Heart, Lung and Blood Institute to investigate respiratory complications affecting premature infants. The NIH has granted funding for our center to continue tracking PROP participants through age 10.
U.S. News & World Report consistently ranks us among the best children’s hospitals in the U.S. We are honored to make the list of best hospitals in all 10 specialties ranked.
You know your child best. So we work with you to create a specialized healthcare plan based on what is best for your child’s health. At Children’s Hospital, you are always a key member of your child’s care team.
We offer a full range of tests, treatments, and services including: